By ClinicalStudyConnect.com Research Desk
Vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol) are both sold as supplements. Head-to-head studies that compare them mostly measure one thing: how much each form raises the blood level of 25-hydroxyvitamin D, written 25(OH)D. On that measure, the evidence leans toward D3, though not in every study and not for every dosing pattern. On the outcome many readers care about more, fewer broken bones, the sources checked for this article do not show a D2-versus-D3 winner. In a large Cochrane review, vitamin D alone did not prevent fractures in older adults, and no reviewed source shows that a higher dose protects bones better.
This page explains what the D3-versus-D2 studies compared, why a blood number doesn’t equal a bone outcome, and how a clinician’s plan can differ from what a trial tested. It does not recommend a form, a dose, or a product.
What Studies Compare When They Compare D3 and D2
According to the NIH Office of Dietary Supplements, the two forms differ chemically only in their side-chain structure. Both are well absorbed in the gut, both raise blood 25(OH)D, and they appear equally able to cure rickets. Most steps in how the body processes them are identical.
The difference shows up in the blood level. The same fact sheet says most evidence indicates that D3 raises 25(OH)D further and keeps it higher for longer. A 2012 systematic review and meta-analysis by Tripkovic and colleagues in the American Journal of Clinical Nutrition reviewed 10 randomized trials (1,016 adults) that directly compared the two forms and pooled seven of them. Overall, D3 raised 25(OH)D more, and the authors suggested it could become the preferred choice for supplementation. Two of the trials found the forms equally effective.
The authors also named limits worth knowing:
- The advantage was clear for large, infrequent “bolus” doses, but the difference was not statistically significant for daily supplements.
- The trials were small (19 to 89 people), used very different doses and schedules, and disagreed more than usual.
- Most tested doses were well above the standard recommended intake, so the results say little about low daily amounts.
- The review could not check whether results differ by age, sex, or ethnicity, and it called for larger trials.
Look at what these studies measure. A typical comparison trial, such as a registered study of D2 versus D3 in healthy adults aged 21 to 65, lists its main outcome as the rise in blood 25(OH)D over 12 weeks. That tells you which form moves a lab value more. It does not tell you which form builds stronger bone.
Why a Higher Blood Number Is Not the Same as Stronger Bones
The NIH fact sheet is direct about this limit: it says 25(OH)D marks how much vitamin D you have taken in, but whether it also marks an effect on health is unclear. It adds that the blood level linked to bone health has not been firmly established, and that lab methods vary enough that a result can read falsely high or low depending on the assay.
Bone research often has this problem. Our guide to collagen supplement research notes that collagen bone studies rely on biomarkers rather than fractures or bone density scans, and that a marker change doesn’t prove a bone outcome. The same caution applies when you read a D3-versus-D2 headline.
What Fracture Trials Found
When researchers count fractures instead of measuring blood levels, the picture changes. A 2014 Cochrane review by Avenell and colleagues pooled 53 trials (91,791 people) of vitamin D and related forms in older adults, with and without calcium. Its findings:
- Vitamin D alone, in the formats and doses tested, was unlikely to prevent hip fractures or any type of fracture.
- Vitamin D plus calcium reduced hip fractures slightly. The review estimated about one fewer hip fracture per 1,000 older adults per year among people living in the community, and about nine fewer per 1,000 among people living in institutions, where baseline risk is much higher.
- Side effects were small but real: vitamin D was associated with higher blood calcium, and the review found a small increase in stomach symptoms and kidney disease with vitamin D plus calcium.
Because that review grouped D2, D3, and related forms together, it cannot say whether D3 protects bone better than D2. The sources checked for this article include no trial that directly compared D2 with D3 on fractures, so that question remains open.
A newer large trial points the same direction. The NIH fact sheet describes a 2022 analysis of the VITAL trial: 25,871 generally healthy adults took 2,000 IU of vitamin D3 daily or a placebo for a median of 5.3 years, and the vitamin D group did not have fewer total, hip, or nonvertebral fractures. Most participants already had adequate blood levels at baseline, which matters when you consider who the results apply to.
More Is Not Automatically Better
It is tempting to assume a bigger dose means stronger protection. The evidence does not support that shortcut. The NIH fact sheet reports that the U.S. Preventive Services Task Force found insufficient evidence to judge the benefits and harms of vitamin D and calcium for preventing fractures in healthy, community-dwelling adults 50 and older, and could not determine the balance of benefit and harm at higher doses.
There is also a safety side. The same fact sheet notes that vitamin D toxicity, which can cause high blood calcium, almost always comes from supplements, and that the Food and Nutrition Board warned that even intakes below the tolerable upper level might have adverse effects over time. Dose and eligibility are individual decisions, so this page stops short of numbers.
When a Prescribed Regimen Might Differ From What a Trial Tested
A trial gives an average result for a defined group. A clinician starts from you. The NIH fact sheet lists several situations where vitamin D needs or handling can differ:
- Conditions that limit fat absorption, such as celiac disease, Crohn’s disease, ulcerative colitis, cystic fibrosis, and some liver diseases, because vitamin D is fat-soluble.
- Obesity or gastric bypass surgery, where people may need different intakes to reach similar blood levels.
- Older age, limited sun exposure, and darker skin, which affect how much vitamin D the body makes or has available.
- Certain medicines: orlistat can reduce absorption, corticosteroids can impair vitamin D handling, thiazide diuretics combined with vitamin D can raise blood calcium, and high vitamin D intakes might reduce the potency of some statins.
For people with diagnosed osteoporosis, the National Institute of Arthritis and Musculoskeletal and Skin Diseases notes that prescribed medicines can help prevent fractures and that a diet rich in calcium and vitamin D supports bone health. Vitamin D is one piece of a plan that a clinician builds around bone density, fracture history, and other risk factors.
Diet can also steer the form. According to the NIH fact sheet, D2 is made by irradiating ergosterol from yeast, while D3 is typically made from lanolin in sheep’s wool; a lichen-based D3 option exists for people who avoid animal products. Anyone with a sourcing question can ask the manufacturer.
Bone-Health Evidence Card: Vitamin D3 vs D2
- Reader goal: Understand whether the form of vitamin D matters for bone health before deciding whether to discuss a supplement.
- Test or risk context: Blood 25(OH)D is the usual lab marker, but assays vary, and the U.S. Preventive Services Task Force found insufficient evidence on screening healthy adults without symptoms, according to the NIH fact sheet. Osteoporosis often causes no symptoms until a bone breaks, per NIAMS, and risk factors include age, family history, low calcium and vitamin D intake, and some long-term medicines.
- Intervention studied: Oral D2 and D3 supplements. Most comparison trials track blood 25(OH)D; the Cochrane review pooled fracture trials for D2, D3, and related forms, alone or with calcium.
- Comparison: In the 2012 meta-analysis, D3 came out ahead overall on blood levels, but not significantly with daily dosing. On fractures, no direct D3-versus-D2 comparison was found in the sources reviewed.
- Evidence limits: A blood marker is not a bone outcome. The D3-versus-D2 trials were small and varied. Vitamin D alone did not prevent fractures in the Cochrane review. VITAL enrolled mostly people with adequate baseline levels.
- Medicine or interaction question: Do any of my medicines, such as steroids, thiazide diuretics, statins, or orlistat, change how I should approach vitamin D or calcium?
- Discussion prompt for a clinician: Given my age, medicines, and bone-health risk factors, do I need a vitamin D blood test or a supplement at all, and if so, which form and how much?
Your Next Step: Check Whether a Supplement Is Needed
The useful question is rarely “D3 or D2?” It is “do I need a supplement at all?” Before buying anything, bring a short list to your clinician or pharmacist: every medicine and supplement you take, your diet and sun exposure, any past fractures or family history of osteoporosis, and any digestive condition that affects absorption. If you already take vitamin D, check the label for the form, or ask the manufacturer, so you can tell your clinician exactly what you take.
For background on how vitamin D research is designed, see our Vitamin D Clinical Research Landscape guide. For the calcium side of the story, see Calcium: Benefits, Doses Studied, Safety and What Studies Show. More bone and joint coverage is gathered on our Bones, Joints and Muscle page.
Educational Disclaimer
This article is for educational purposes only and is not medical advice. It does not diagnose any condition, recommend any product, or tell you to start, stop, or change any supplement or medication. Research changes over time, and individual needs vary. Talk with a qualified healthcare provider before making decisions about vitamin D, calcium, or bone-health medicines, especially if you are pregnant, breastfeeding, managing a health condition, or taking medication. See our Medical Disclaimer.